Drug
Darifenacin clinical trials
Also written Enablex.
- studies test it
- 19
- open now
- 1
- in phase 3
- 3
- first study started
- 2002
Keep track of what changes. Save the darifenacin studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
19 studies that test it; most in 2006 (3)
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 3 |
| 2009 | 3 |
| 2010 | 2 |
| 2014 | 1 |
| 2022 | 1 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 5
- Phase 2
- 5
- Phase 3
- 3
- Phase 4
- 5
- No phase
- 2
What it is tested for
Each study’s main condition, where its own words name it.
- Pain
- 1
Who runs them
Industry 11 · Other 8
Novartis (8) · Center for Clinical Pharmacology Research Bdbeq S.A. (2) · Ain Shams University (1) · Universidad de Valparaiso (1) · US Department of Veterans Affairs (1) · Toronto Rehabilitation Institute (1) · Oliver Blanchard (1) · Warner Chilcott (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses darifenacin is read from its arms, and is right about nine times in ten.
Testing it · 19
- A Study to Assess the Safety, Tolerability, and Pharmacology of Darifenacin in Patients With ALSRecruitingPhase 2Oliver BlanchardNCT06249867Written as Darifenacin 7.5 MG Extended Release Oral Tablet
- Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTSCompletedPhase 1/2Ain Shams UniversityNCT07206706Written as Darifenacin 7.5 MG
- A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor OveractivityTerminatedPhase 2Warner ChilcottNCT00712322Written as Darifenacin
- Efficacy, Safety, and Tolerability of Darifenacin in Patients Aged > 65 Years With Overactive BladderCompletedPhase 4NovartisNCT00171184Written as Darifenacin
- Preoperative Use of Darifenacin (Enablex) to Alleviate Postoperative Ureteral Stent PainTerminatedNot applicableUniversity of Missouri-ColumbiaNCT01189071Written as Darifenacin
- Efficacy of Darifenacin and Physiotherapy for the Treatment of Overactive Bladder in WomenCompletedPhase 3Universidad de ValparaisoNCT02143570Written as Darifenacin
- Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime WakefulnessWithdrawnPhase 4Cognitive Research CorporationNCT01018225Written as darifenacin
- Study to Compare How the Body Changes the Blood Level of Darifenacin Tablet Form vs. the Modified Release Liquid Form in Healthy SubjectsCompletedPhase 1NovartisNCT00413426Written as Darifenacin (DAR328)
- Study of Darifenacin in Patients Suffering From Multiple Sclerosis and Neurogenic Detrusor OveractivityTerminatedPhase 2BayerNCT00845338Written as Darifenacin (BAY79-4998)
- Anticholinergic Therapy for Overactive Bladder in Parkinson's DiseaseCompletedNot applicableUS Department of Veterans AffairsNCT00892450Written as Oxybutynin and darifenacin
- Comparative Study of the Efficacy and Safety of Muscarinic M3 Receptors Antagonists in the Treatment of Neurogenic Detrusor OveractivityCompletedPhase 4Toronto Rehabilitation InstituteNCT00800462Written as Darifenacin Hydrogen Bromide (HBr)
- Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy SubjectsCompletedPhase 1NovartisNCT00703703Written as Darifenacin
- Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.Status unknownPhase 1Center for Clinical Pharmacology Research Bdbeq S.A.NCT01229280Written as Darifenacin
- Single Dose Two-periods Crossover Bioequivalence Study of Darifenacin Tablets in Healthy Volunteers.Status unknownPhase 1Center for Clinical Pharmacology Research Bdbeq S.A.NCT01227811Written as Darifenacin
- Cognitive Effects of Darifenacin and Oxybutynin Extended Release in Volunteers Aged 60 and OverCompletedPhase 2NovartisNCT00170768Written as Darifenacin
- A 12-Week Study to Evaluate the Efficacy of Darifenacin to Increase the Warning Time in Patients With Overactive Bladder.CompletedPhase 3NovartisNCT00171145Written as Darifenacin
- A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive BladderCompletedPhase 3NovartisNCT00170755Written as Darifenacin
- Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive BladderCompletedPhase 4NovartisNCT00366002Written as Darifenacin
- Pharmacologic Effects of Darifenacin and Tolterodine on Cardiovascular Parameters in Healthy SubjectsCompletedPhase 4NovartisNCT00413790Written as Darifenacin
Given in every arm · 1 — darifenacin is usual care beside what is tested
As the comparator · 1 — what is tested is compared with darifenacin
Codes
What other systems call darifenacin · ClinicalTrials.gg INT003929
- MeSH (NLM) C101207darifenacinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) APG9819VLMDARIFENACINConfirmed FDA, NLM, Wikidata
- RxNorm 136198Confirmed FDA, Wikidata
- Wikidata Q166476darifenacinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C65363DarifenacinOne source FDA
- DrugBank DB00496One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C101207 | darifenacin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | APG9819VLM | DARIFENACIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 136198 | — | Confirmed FDA, Wikidata |
| Wikidata | Q166476 | darifenacin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C65363 | Darifenacin | One source FDA |
| DrugBank | DB00496 | — | One source Wikidata |
Also registered as darifenacin hydrobromide (UNII CR02EYQ8GV · RxNorm 485417).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.